NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/15/2022
Back to search
Official data from USPTO
HEMOCYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/15/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/05/1999
Registration date
01/21/2003
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2022
Last transaction
07/15/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1955-04-00
First use in commerce
1955-04-00
Drawing code
1
Owner type
03
Owner location
Decatur, GA, US
Examiner
DEFORD, JEFFREY S
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U. C. (pessoa física)
Representatives
Linda Krebs US Pharmaceutical Corporation
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
vitamin and mineral supplementiron mineral complex tablets
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/15/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/15/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/15/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
02/04/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/21/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/28/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/28/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/28/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
12/04/2012
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/08/2012
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/08/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/16/2009
PLGL
ASSIGNED TO PARALEGAL
01/08/2009
E815
TEAS SECTION 8 & 15 RECEIVED
01/06/2009
CFIT
CASE FILE IN TICRS
03/19/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2003
PUBO
PUBLISHED FOR OPPOSITION
10/29/2002
NPUB
NOTICE OF PUBLICATION
10/09/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2002
ZZZY
PREVIOUS ACTION COUNT WITHDRAWN
04/23/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2002
PAPER RECEIVED
03/28/2002
DOCK
ASSIGNED TO EXAMINER
12/19/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2001
CNRT
NON-FINAL ACTION MAILED
02/23/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2000
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2000
CNRT
NON-FINAL ACTION MAILED
03/10/2000
DOCK
ASSIGNED TO EXAMINER
02/02/2000
Continuous trademark protection
Get notified about every new filing that threatens HEMOCYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.